Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

01.12.2016 | original article | Ausgabe 23-24/2016

Wiener klinische Wochenschrift 23-24/2016

Association between apolipoprotein B EcoRI polymorphisms and coronary heart disease

A meta-analysis

Zeitschrift:
Wiener klinische Wochenschrift > Ausgabe 23-24/2016
Autoren:
Yeda Chen, Jingtang Zeng, Yiqing Tan, Min Feng, Jiheng Qin, Meihua Lin, Xiang Zhao, Xiaolei Zhao, Yan Liang, Naizun Zhang, Dr. Shaoqi Rao
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1007/​s00508-016-1072-z) contains material which is available to authorized users.

Summary

Objective

The study was carried out to examine the association between apolipoprotein B (ApoB) EcoRI polymorphism (E- vs. E+) (rs1042031) and coronary heart disease (CHD) risk by systematically analyzing multiple independent studies.

Methods

The Hardy-Weinberg equilibrium (HWE) test was applied to assess genotype frequency distribution in healthy controls. The quality of the studies was assessed using the Newcastle-Ottawa scale (NOS). Power analysis was performed with Power and Precision V4 software. A fixed effect model was used because no deviation from homogeneity was found. Publication bias was quantified and examined with Begg’s funnel plot test and Egger’s linear regression method. The meta-analysis was performed by Stata 12.0 software.

Results

A total of 21 eligible association studies were merged in this meta-analysis and the pooled sample consisted of 2994 CHD patients and 3258 healthy controls. No significant publication bias and heterogeneity were observed in these studies. The pooled odds ratio (OR) and 95% confidence interval (CI) of E vs. E+ were 1.18 (1.06–1.32). The pooled OR (95% CI) of E+ E + E E vs. E+ E+ was 1.18 (1.04–1.34).

Conclusions

This meta-analysis indicated that ApoB EcoRI confers a moderate risk for CHD and the E allele at this locus might be a susceptibility allele for the development of CHD.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Zusatzmaterial
Checklist S1 PRISMA 2009 Checklist.
508_2016_1072_MOESM1_ESM.doc
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 23-24/2016

Wiener klinische Wochenschrift 23-24/2016 Zur Ausgabe

images in clinical medicine

Adult patent ductus arteriosus